Modeling the within-host dynamics of Plasmodium vivax hypnozoite activation: An analysis of the SPf66 vaccine trial
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2401024121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Somya Mehra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand. Hauptthemen laut MEDLINE: Plasmodium vivax, Malaria, Vivax. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Australian Research Council.
Abstract (Originalsprache)
Plasmodium vivax parasites can lie dormant in the liver as hypnozoites, activating weeks to months after sporozoite inoculation to cause relapsing malarial illness. It is not known what biological processes govern hypnozoite activation. We use longitudinal data from the most detailed cohort study ever conducted in an area where both Plasmodium falciparum and P. vivax were endemic to fit a simple within-host mathematical model of P. vivax hypnozoite activation. 1,344 children living on the Thailand–Myanmar border were followed daily for 21 mo. There were 2,504 vivax and 1,164 falciparum malaria symptomatic episodes recorded over 1988 person-years. The model assumes that hypnozoites activate independently at a constant rate (“exponential clock model”). When this model was embedded in a stochastic framework for repeated infectious mosquito bites, with seasonality inferred from the incidence of clinical falciparum malaria episodes, it explained the observed temporal patterns of multiple (up to 13) recurrent vivax malaria episodes. Under this model, we estimate the mean dormancy period for a single hypnozoite to be 6 mo (i.e., a half-life of 4 mo). We use the calibrated within-host model to characterize population-level overdispersion in the risk of relapse, and assess the potential utility of a serological test for radical cure in low transmission settings. We show that mefloquine treatment of falciparum malaria eliminates early vivax relapses; and that there are substantially more P. vivax recurrences than expected under the model following artesunate monotherapy treatment for falciparum malaria. These results suggest that hypnozoites can be activated by symptomatic malarial illness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.
- School of Mathematics and Statistics, The University of Melbourne, Parkville, VIC 3010, Australia.
- Shoklo Malaria Research Unit, Mae Sot, Tak, 63110, Thailand.
- Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7LF, United Kingdom.
- Infectious Diseases Data Observatory, Big Data Institute, Oxford OX3 7LF, United Kingdom.
ORCID-Profile: Somya Mehra, François Nosten, Nicholas J White, James A Watson
Förderung
- Wellcome Trust
- Australian Research Council
Zitieren
APA
Mehra, S., Nosten, F., Luxemburger, C., White, N. J., & Watson, J. A. (2024). Modeling the within-host dynamics of Plasmodium vivax hypnozoite activation: An analysis of the SPf66 vaccine trial. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2401024121
Vancouver
Mehra S, Nosten F, Luxemburger C, White NJ, Watson JA. Modeling the within-host dynamics of Plasmodium vivax hypnozoite activation: An analysis of the SPf66 vaccine trial. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2401024121
BibTeX
@article{Mehra2024,
author = {Mehra, Somya and Nosten, François and Luxemburger, Christine and White, Nicholas J and Watson, James A},
title = {Modeling the within-host dynamics of Plasmodium vivax hypnozoite activation: An analysis of the SPf66 vaccine trial},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2401024121}
}
EUVIMED